Source-backed aggregate guide - manual-review caution Canine Urinary-Renal Renal urinaryEmergency sorting

Canine renal and urinary decision guide: obstruction, infection, kidney injury, proteinuria, and stones

Separate emergency obstruction and AKI from cystitis, pyelonephritis, CKD, proteinuria, urolithiasis, incontinence, and bladder tumors.

⏱ 7-9 min read · Topic 57 of 141

5
Practice Qs
6
Traps
High
Exam freq.
Your status
Study step
Classic NAVLE presentation
First gate
Can the dog urinate, is potassium/perfusion dangerous, and is pain or obstruction present?
Renal split
AKI is acute trend and perfusion/toxin/infection; CKD is chronic trend and staging context.
Urinary split
Cystitis, pyelonephritis, urolithiasis, obstruction, incontinence, and tumor have different next steps.
Exam habit
Use urinalysis, culture context, imaging, protein quantification, and emergency signs in sequence.
High-yield takeaways
  • Recognize the classic presentation, then narrow the case using signalment, timeline, exam findings, diagnostics, and response to treatment.
  • Use the decision framework, traps, differentials, and related questions to rehearse NAVLE-style next-best-step reasoning.
  • This educational study page is not a clinical protocol; confirm patient-specific decisions with current references and clinician judgment.
30-second revision
EmergencyAnuria/stranguria, painful bladder, potassium/perfusion risk first.
AKI vs CKDUse timeline, USG, trend, imaging, toxin/infection/obstruction context.
UTICystitis is not pyelonephritis, stones, tumor, obstruction, or proteinuria.
Protein/BPPersistent proteinuria needs quantification and blood-pressure context.
Follow-upCulture, imaging, renal trend, recurrence, and warning signs matter.
How NAVLE tests this topic
Obstruction first → Stranguria/anuria, painful bladder, hyperkalemia, or azotemia changes urgency immediately.
AKI versus CKD → Timeline, urine concentration, hydration, imaging, toxin exposure, and prior labs separate branches.
Infection level → Simple cystitis differs from pyelonephritis by fever, renal pain, systemic illness, and culture context.
Protein/stones/tumor → Proteinuria, urolithiasis, and bladder tumors need targeted workup rather than generic UTI treatment.
Emergency Triage Alert
Obstruction and unstable azotemia are emergency branches

A dog that cannot urinate, is systemically ill, has suspected hyperkalemia, or has rapidly worsening kidney values needs stabilization and reassessment before routine outpatient UTI planning.

Clinical review note
Manual-review caution

This guide is educational NAVLE-style study material. Confirm clinical protocols, medication choices, procedure timing, and referral decisions against current references and clinician judgment.

Key clinical patterns
Core pattern
Stranguria, anuria, painful bladder, or obstructive signsAcute azotemia, toxin exposure, dehydration, or infection riskChronic PU/PD, weight loss, poor appetite, or prior renal changesPollakiuria, dysuria, hematuria, fever, or renal painPersistent proteinuria, recurrent stones, incontinence, or mass-like signs
Supporting clues
Urine specific gravity and sedimentCulture and sensitivity contextSerum potassium and acid-base/electrolyte trendImaging for stones, obstruction, mass, or kidney architectureBlood pressure and protein quantification
NAVLE trigger: NAVLE-style urinary questions reward branch separation before choosing antibiotics, imaging, catheterization, biopsy, or chronic monitoring.
Decision framework - what NAVLE asks
Urethral obstruction branch
Assess perfusion, potassium risk, bladder status, pain, and urgent decompression pathway.
AKI/systemic branch
Stabilize perfusion, identify toxin/infection/obstruction, and monitor trend before chronic labels.
Cystitis/UTI branch
Use urinalysis and culture context; avoid calling systemic illness simple cystitis.
Pyelonephritis branch
Fever, renal pain, systemic illness, and renal pelvis context raise upper-tract infection concern.
Proteinuria/CKD/stones/tumor branch
Quantify protein, image stones/masses, stage CKD, and plan follow-up rather than repeating empiric treatment.
Diagnostic priorities and interpretation
Urine flow
Emergency discriminator
Anuria/stranguria/painful bladder changes priority.
USG/sediment
Renal/urinary discriminator
Concentration, casts, cells, crystals, and bacteria shape branch selection.
Culture
Infection discriminator
Culture matters for recurrent, complicated, upper-tract, or resistant patterns.
Protein/BP
Glomerular/CKD discriminator
Persistent proteinuria and hypertension require targeted follow-up.
Imaging
Obstruction/mass/stone discriminator
Stones, masses, and obstruction should not be reduced to routine cystitis.
Educational caution: this guide does not provide catheterization, antimicrobial, fluid, potassium, or renal-dose protocols.
Treatment escalation and management logic
Emergency
Prioritize obstruction, severe azotemia, hyperkalemia risk, pain, and perfusion before routine testing.
Use current references for decompression and stabilization protocols.
Diagnose
Use urinalysis, culture, renal values, electrolytes, imaging, protein quantification, and BP according to branch.
Testing is branch-specific.
Treat branch
Separate cystitis, pyelonephritis, AKI, CKD, stones, proteinuria, tumor, and incontinence before therapy.
Avoid generic UTI treatment for every urinary sign.
Monitor
Track renal trend, recurrence, culture results, proteinuria, BP, imaging, and owner warning signs.
Follow-up is part of the answer.
NAVLE traps — where students lose marks
Calling every urinary sign cystitis
Obstruction, pyelonephritis, stones, tumors, and renal disease can mimic lower urinary signs.
Missing urethral obstruction urgency
Anuria/stranguria with painful bladder can become a potassium and perfusion emergency.
Labeling AKI as CKD from one azotemic panel
Timeline, urine concentration, hydration, imaging, and prior labs matter.
Treating pyelonephritis as simple cystitis
Fever, renal pain, systemic illness, and renal pelvis clues change workup and management.
Ignoring persistent proteinuria
Glomerular disease and CKD risk require quantification and BP context.
Repeating empiric therapy without imaging/culture context
Recurrent signs, stones, tumors, and resistance require targeted investigation.
Related questions
Practice canine urinary/renal branch selection and emergency sorting.
0 / 0
Q1Obstruction
A male dog strains repeatedly, produces no urine, has a painful distended bladder, and is dull. Which branch is most urgent?
Q2AKI vs CKD
A dog has acute azotemia after toxin exposure and previously normal renal values. Which interpretation is safest?
Q3Upper UTI
A dog has fever, renal pain, bacteriuria, and systemic illness. Which branch is more appropriate than simple cystitis?
Q4Proteinuria
A dog has persistent proteinuria on repeat testing. What should the next reasoning include?
Q5Recurrent signs
A dog has recurrent hematuria despite repeated empiric therapy. Which missing step is most concerning?